Skip to Content
Merck
  • Preparing amorphous hydrophobic drug nanoparticles by nanoporous membrane extrusion.

Preparing amorphous hydrophobic drug nanoparticles by nanoporous membrane extrusion.

Nanomedicine (London, England) (2012-09-05)
Peng Guo, Tammy M Hsu, Yaping Zhao, Charles R Martin, Richard N Zare
ABSTRACT

The aim of the present study was to develop a simple and straightforward method for formulating hydrophobic drugs into nanoparticulate form in a scalable and inexpensive manner. The nanoporous membrane extrusion (NME) method was used to prepare hydrophobic drug nanoparticles. NME is based on the induced precipitation of drug-loaded nanoparticles at the exits of nanopores. Three common hydrophobic drug models (silymarin, β-carotene and butylated hydroxytoluene) were tested. The authors carefully investigated the morphology, crystallinity and dissolution profile of the resulting nanoparticles. Using NME, the authors successfully prepared rather uniform drug nanoparticles (∼100 nm in diameter). These nanoparticles were amorphous and show an improved dissolution profile compared with untreated drug powders. These studies suggest that NME could be used as a general method to produce nanoparticles of hydrophobic drugs.

MATERIALS
Product Number
Brand
Product Description

Supelco
Butylated Hydroxytoluene, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Butylated hydroxytoluene, ≥99%, FCC, FG
Supelco
3,5-Di-tert-butyl-4-hydroxytoluene, analytical standard
Sigma-Aldrich
2,6-Di-tert-butyl-4-methylphenol, tested according to Ph. Eur.
Sigma-Aldrich
2,6-Di-tert-butyl-4-methylphenol, purum, ≥99.0% (GC)
Butylhydroxytoluene, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
2,6-Di-tert-butyl-4-methylphenol, ≥99.0% (GC), powder